BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Prognosis
3355 results:

  • 1. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q; Huang J; Zhang Q; Zhao J
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
    Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
    BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]    [Full Text] [Related]  

  • 6. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
    Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
    Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    Zhang Y; Li L; Han Q; Wen L
    J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
    Li X; Ou C; He A
    Medicine (Baltimore); 2024 Apr; 103(14):e37680. PubMed ID: 38579053
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Zeng S; Yang P; Xiao S; Liu L
    Sci Rep; 2024 Apr; 14(1):7681. PubMed ID: 38561337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
    Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
    Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
    BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
    Li N; Chen Q; Li B
    Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
    Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
    Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial cancer Cells.
    Tian S; Ren L; Liu C; Wang Z
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474453
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Postoperative lymph node metastasis status and related factors in patients with early-stage, low-risk endometrial cancer assessed by the Mayo criteria].
    Shi XW; Wang DF; Zhang GN; Zhang J
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):736-741. PubMed ID: 38462353
    [No Abstract]    [Full Text] [Related]  

  • 17. CD146
    Yu Z; Zhang Q; Wei S; Zhang Y; Zhou T; Zhang Q; Shi R; Zinovkin D; Pranjol ZI; Zhang J; Wang H
    Cell Commun Signal; 2024 Mar; 22(1):170. PubMed ID: 38459564
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
    Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
    Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    Olaleye OO; Kim DH; Spriggs KA
    BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial.
    Koeneman BJ; Schreibelt G; Gorris MAJ; Hins-de Bree S; Westdorp H; Ottevanger PB; de Vries IJM
    Front Immunol; 2024; 15():1368103. PubMed ID: 38444861
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 168.